ATON SA: New Phase of Valorization of its Technological Assets

The ATON SA group is initiating a dynamic process to enhance the value of its technological assets, highlighting the evolution of its subsidiaries. The company has repositioned itself around its ambition: to support the growth of disruptive technological players in the life sciences. ATON relies on three promising subsidiaries: Inoviem Scientific, PIMS Technology, and B Cell Design. Each excels in its field, boosting the group's overall potential. Financially, ATON has strengthened its structure in 2024, with cash of €0.7 million as of August 31, 2025, consolidated by research tax credits. A videoconference is scheduled for October 30 to detail the group's strategic progress and long-term orientations.